Latest Reports
Annual Report 2009(PDF 685 KB)
Investor Relations
The VITA 34 International AG as the holding company combines the operational business of its subsidiaries VITA 34 AG and Secuvita, S.L. Since 1997, VITA 34 has been focusing on the long-term storage of umbilical cord blood and the production of stem cell transplants of the highest quality and safety. It is their aim to become one of the leading suppliers of cell products in the field of Regenerative Medicine.